Beta-adrenoceptor modulation and heart rate variability--the value of scatterplot measures of compactness

Area of Science:

• Cardiology
• Physiology
• Data Analysis

Background:

• Heart rate variability (HRV) analysis using scatterplots (Poincaré plots) assesses cardiac autonomic function.
• Traditional 2D scatterplots may not fully capture complex HRV dynamics.
• Novel methods analyzing scatterplot density offer potential for improved characterization.

Purpose of the Study:

• To compare traditional scatterplot parameters with novel density-based measures for HRV analysis.
• To assess the effectiveness of "heart rate variability fraction" and "compactness" in characterizing HRV.
• To determine if these methods improve the prediction of cardiovascular outcomes.

Main Methods:

• Construction of Poincaré plots (RR vs. RR(n-1)) from HRV data.
• Application of geometric and topological analyses, including "compactness" and "HRV fraction."
• Comparison of these measures against conventional scatterplot parameters in healthy subjects receiving beta-adrenoceptor agents or placebo.

Main Results:

• Salbutamol, pindolol, and xamoterol significantly increased compactness and reduced HRV fraction compared to placebo.
• The novel density-based methods (compactness, HRV fraction) were less discriminating than conventional scatterplot parameters.
• Significant differences were observed in HRV fraction and compactness with specific beta-blockers and agonists.

Conclusions:

• Current density-based scatterplot analysis methods (HRV fraction, compactness) show potential but require further refinement.
• These novel methods were less effective than traditional parameters in discriminating HRV under pharmacological intervention.
• Further research is needed to develop improved scatterplot analysis techniques, possibly by combining multiple features.